During the past decade, Institute Asthma and Allergy conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institute Asthma and Allergy" #1 collaborator was "Takeda Development Center Americas, Inc." with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Institute Asthma and Allergy" are "Hereditary Angioedema (HAE)" (3 trials), "Angioedema" (2 trials) and "Hereditary Angioedema" (1 trials). Many other conditions were trialed in "Institute Asthma and Allergy" in a lesser frequency.

Most popular intervention types in "Institute Asthma and Allergy" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Lanadelumab" (2 trials), "DX-2930" (1 trials), "Lanadelumab 150 mg" (1 trials), "Lanadelumab 300 mg" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institute Asthma and Allergy" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Institute Asthma and Allergy". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Institute Asthma and Allergy, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Institute Asthma and Allergy, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".